HOME › DRUGS › LUSPATERCEPT
ACTIVE SUBSTANCE / INN

LUSPATERCEPT

Brand name(s): Reblozyl
EMA LISTED
AUTHORISED
Anemia;Myelodysplastic Syndromes;beta-Thalassemia
ACTIVE SUBSTANCE
Luspatercept
REGULATORS
EMA
SPONSORS / MAH
Bristol Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ReblozylBristol Myers Squibb Pharma EEIGAuthorised25/06/2020Anemia;Myelodysplastic Syndromes;beta-Thalassemia

FULL INTELLIGENCE ON LUSPATERCEPT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →